Dynavax Technologies Corporation

04/06/2021 | Press release | Distributed by Public on 04/06/2021 04:07

Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant